Ad
related to: vertex pharmaceuticals nasdaq
Search results
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded by StockNews.com to “Strong-Buy”
ETF DAILY NEWS· 2 days agoStockNews.com upgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a buy rating to a strong-buy rating in a report ...
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know - Vertex Pharmaceuticals (NASDAQ...
Benzinga· 7 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals . Looking at options history ...
Is CRISPR Therapeutics Stock a Buy?
Motley Fool via Yahoo Finance· 5 days agoCRISPR Therapeutics (NASDAQ: CRSP) is a star in the gene-editing therapy niche. The company made tremendous progress over the past few years, culminating...
Evercore ISI’s latest rating for VRTX stock – Knox Daily
Knox Daily· 2 days agoIt rated VRTX as “a Mkt perform” which previously was an “an Outperform”. Price Performance Review of VRTX On Friday, Vertex Pharmaceuticals, Inc. [< ...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 7 days agoMeanwhile, the company's Casgevy treatment for sickle cell anemia, developed in partnership with ...
BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
TipRanks via Yahoo Finance· 5 days agoLast week, Bluebird Bio (NASDAQ:BLUE) shares climbed while CRISPR Therapeutics (NASDAQ:CRSP) stock...
Is Bluebird Bio Stock a Buy?
Motley Fool via Yahoo Finance· 6 days agoCasgevy, another gene-editing treatment for SCD and TDT, earned approval recently. The team of Vertex Pharmaceuticals and CRISPR Therapeutics developed...
Indian-descent Nikesh Arora 2nd highest paid CEO in US, says report
Investing.com· 1 day agoIndian-descent Nikesh Arora 2nd highest paid CEO in US, says report
Dell Technologies' market cap exceeds $100B for the first time - Boston Business Journal
The Business Journals· 7 days agoThe market value of Dell Technologies crossed the $100 billion threshold for the first time while...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 days agoU.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership team with the appointment of Christopher J.
Ad
related to: vertex pharmaceuticals nasdaq
